华北制药 (600812.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(华北制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 2,557,512,113.0410,120,201,384.847,974,681,092.805,233,404,242.632,660,096,706.2210,499,947,065.677,873,258,693.275,278,695,208.782,543,401,447.14
 营业利润(元) 57,678,495.87156,453,221.39120,992,425.0482,518,686.6736,450,940.95-567,633,665.63132,456,850.0896,577,227.1641,184,658.02
 利润总额(元) 58,024,653.96158,535,685.79127,084,369.4887,297,997.8738,795,019.53-565,074,477.16134,265,998.2897,231,450.0842,184,107.91
 净利润(元) 32,794,050.3149,387,877.2250,382,686.4242,803,558.026,546,123.55-678,781,570.9654,735,327.9443,463,497.2419,196,750.52
 归属于母公司股东的净利润(元) 18,152,447.094,890,347.2227,973,093.7026,545,580.145,420,341.81-689,231,500.0037,935,682.0932,375,502.3613,681,778.22
盈利能力:
 销售毛利率(%) 30.5931.9831.7332.7733.4033.3833.0332.9033.42
 销售净利率(%) 1.280.490.630.820.25-6.460.700.820.75
 净资产收益率(%) 0.340.090.490.470.10----
 总资产报酬率ROA(%) 0.812.992.151.400.73----
 投入资本回报率ROIC(%) 0.110.030.170.160.03-3.720.200.160.07
营运能力:
 存货周转率(次) 0.692.682.041.360.71----
 应收账款周转率(次) 1.104.863.492.161.14----
 总资产周转率(次) 0.120.480.360.230.11----
偿债能力:
 资产负债率(%) 69.8070.0870.8870.3771.4370.6569.9372.5472.02
 股东权益比率(%) 25.5525.3624.7825.2424.3124.9826.0523.8024.25
 已获利息倍数(倍) 1.501.341.361.371.29-0.021.331.341.30
 流动比率 0.810.780.820.810.780.720.760.860.88
 速动比率 0.510.490.550.550.540.490.550.670.70
发展能力:
 营业收入增长率(%) -3.86-3.621.29-0.864.591.11-3.83-5.45-6.25
 营业利润增长率(%) 58.24127.56-8.66-14.56-11.49-517.2851.7097.75214.16
 税后利润增长率(%) 234.89100.71-26.26-18.01-60.38-3,780.33113.393,121.28123.92
 净资产增长率(%) 0.540.29-11.63-11.49-13.04-12.91-1.06-0.930.52
 总资产增长率(%) -4.33-1.25-7.12-16.52-13.27-14.88-9.54-0.961.67

前瞻产业研究院